In the present reports of bladder cancer, decreased protein-coding NPM1 transcript levels supported the association of Myc gene expression, aberrant activation of the β-catenin/c-Myc, and the AFF4/NF-κB/Myc signalling pathways to regulate cell activities and promote cancer migration in bladder cancer [9]. The gene discussed is NPM1; the disease is urinary bladder cancer.